Allarity Therapeutics, INC. (ALLR) — 10-K Filings

All 10-K filings from Allarity Therapeutics, INC.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.

10-K Filings (2)

Allarity Therapeutics Files 2024 10-K: Net Loss of $200K — Mar 31, 2025 Risk: high
Allarity Therapeutics, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company reported total assets of $7.3 million and total liabilities
Allarity Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — Mar 8, 2024 Risk: low
Allarity Therapeutics, Inc. (ALLR) filed a Annual Report (10-K) with the SEC on March 8, 2024. Allarity Therapeutics, Inc. filed its annual report on Form 10-K

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX